Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04035187 · ClinicalTrials.gov registry record · Phase 4
Itraconazole Oral Absorption
A Phase 4 study of Fungal Infection, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT04035187 is a Phase 4 study of Fungal Infection that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 17 participants, below the 160-participant average among 6 other Fungal Infection trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04035187, a Phase 4 study of Fungal Infection, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
For tablets to be absorbed, the drug must dissolve after being swallowed. Drugs with low solubility sometimes require the inert ingredients in tablets to help the drug dissolve after being swallowed. This study uses itraconazole as an example drug with low solubility. Itraconazole tablets with different inert ingredients and manufacturing will be administered to healthy volunteers to see if the different inert ingredients and manufacturing impact drug absorption.
Conditions Studied
Interventions
- DRUG fast itraconazole tablet
- DRUG medium itraconazole tablet
- DRUG slow itraconazole tablet
- DRUG oral itraconazole solution
Study Locations (1)
Maryland
- University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2022-05-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04035187
The ClinicalTrials.gov registry entry for NCT04035187 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 6 other Fungal Infection trials with a reported enrollment target (89% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fungal Infection appearing as the primary indexed condition, and to 4 interventions - of which fast itraconazole tablet is the first listed.
NCT04035187 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04035187 about?
NCT04035187 is a clinical study titled "Itraconazole Oral Absorption". For tablets to be absorbed, the drug must dissolve after being swallowed. Drugs with low solubility sometimes require the inert ingredients in tablets to help the drug dissolve after being swallowed. This study uses itraconazole as an example drug with low solubility. Itraconazole tablets with diffe...
What is the current status of trial NCT04035187?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2020-02-10. Estimated completion is 2022-05-21.
What conditions does trial NCT04035187 study?
This clinical trial studies the following conditions: Fungal Infection.
What interventions are being tested in trial NCT04035187?
The interventions under investigation include: fast itraconazole tablet (DRUG), medium itraconazole tablet (DRUG), slow itraconazole tablet (DRUG), oral itraconazole solution (DRUG).
Who is sponsoring clinical trial NCT04035187?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04035187 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fungal Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
RECRUITING · Phase 2
-
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
ACTIVE NOT RECRUITING · Phase 3
-
Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO)
COMPLETED · Phase 1
-
Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
COMPLETED
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
COMPLETED · Phase 2
-
Alternate Day Micafungin: A PK Study in Pediatric Patients
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.